Intraperitoneal chemotherapy for ovarian carcinoma Journal Article


Author: Markman, M.
Article Title: Intraperitoneal chemotherapy for ovarian carcinoma
Abstract: Investigators at several centers have begun to explore the potential utility of the intraperitoneal administration of chemotherapeutic agents as therapy for advanced ovarian carcinoma. Recent pharmacokinetic modeling studies have suggested and initial clinical trials have confirmed an advantage for cavity exposure to certain drugs compared to systemic exposure when the agents are delivered directly into the peritoneal cavity. While objective responses have been observed in patients with refractory disease, there are both practical and theoretical problems with this approach to the treatment of ovarian carcinoma. Eventually randomized controlled trials will be required to define a role for this innovative therapeutic technique.
Keywords: cancer chemotherapy; clinical article; review; cisplatin; doxorubicin; fluorouracil; antineoplastic agents; comparative study; cytarabine; methotrexate; ovarian neoplasms; animal; antineoplastic combined chemotherapy protocols; melphalan; mitoxantrone; ovary carcinoma; rats; infusions, parenteral; pharmacokinetics; peritoneal cavity; intraperitoneal drug administration; human; female
Journal Title: Biomedicine and Pharmacotherapy
Volume: 41
Issue: 8
ISSN: 0753-3322
Publisher: Elsevier Inc.  
Date Published: 1987-01-01
Start Page: 420
End Page: 424
Language: English
PUBMED: 3330457
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 5 February 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Maurie Markman
    124 Markman